COMIRNATY OMICRON XBB.1.5
COMIRNATY OMICRON XBB.1.5
Discontinued
DIN Number
02541866
Drug Class
Human
Market Date
Oct 24, 2023
Company
HC
BioNTech Manufacturing GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02541866
AIG Number0165061004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
J07BN01 COVID-19, RNA-BASED VACCINE
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RAXTOZINAMERANActive
Strength: 3 MCG / 0.2 ML
Monograph: RAXTOZINAMERAN